OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial
Heiko Schöder, Mei‐Yin C. Polley, Michael V. Knopp, et al.
Blood (2020) Vol. 135, Iss. 25, pp. 2224-2234
Open Access | Times Cited: 80
Heiko Schöder, Mei‐Yin C. Polley, Michael V. Knopp, et al.
Blood (2020) Vol. 135, Iss. 25, pp. 2224-2234
Open Access | Times Cited: 80
Showing 1-25 of 80 citing articles:
2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management
Sandra Susanibar‐Adaniya, Stefan K. Barta
American Journal of Hematology (2021) Vol. 96, Iss. 5, pp. 617-629
Open Access | Times Cited: 253
Sandra Susanibar‐Adaniya, Stefan K. Barta
American Journal of Hematology (2021) Vol. 96, Iss. 5, pp. 617-629
Open Access | Times Cited: 253
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial
Sattva S. Neelapu, Michael Dickinson, Javier Muñoz, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 735-742
Open Access | Times Cited: 196
Sattva S. Neelapu, Michael Dickinson, Javier Muñoz, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 735-742
Open Access | Times Cited: 196
PET Molecular Imaging: A Holistic Review of Current Practice and Emerging Perspectives for Diagnosis, Therapeutic Evaluation and Prognosis in Clinical Oncology
Valentin Duclos, Alex Iep, Léa Gomez, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4159-4159
Open Access | Times Cited: 61
Valentin Duclos, Alex Iep, Léa Gomez, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4159-4159
Open Access | Times Cited: 61
PET/CT in Non-Hodgkin Lymphoma: An Update
Lucia Zanoni, Davide Bezzi, Cristina Nanni, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 320-351
Closed Access | Times Cited: 42
Lucia Zanoni, Davide Bezzi, Cristina Nanni, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 320-351
Closed Access | Times Cited: 42
The management of newly diagnosed large B‐cell lymphoma: A British Society for Haematology Guideline
Christopher P. Fox, Sridhar Chaganti, Graham McIlroy, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 4, pp. 1178-1192
Open Access | Times Cited: 11
Christopher P. Fox, Sridhar Chaganti, Graham McIlroy, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 4, pp. 1178-1192
Open Access | Times Cited: 11
The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma
Sally F. Barrington, Judith Trotman
The Lancet Haematology (2020) Vol. 8, Iss. 1, pp. e80-e93
Closed Access | Times Cited: 55
Sally F. Barrington, Judith Trotman
The Lancet Haematology (2020) Vol. 8, Iss. 1, pp. e80-e93
Closed Access | Times Cited: 55
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients
Jakoba J. Eertink, C. N. Burggraaff, Martijn W. Heymans, et al.
Blood Advances (2021) Vol. 5, Iss. 9, pp. 2375-2384
Open Access | Times Cited: 54
Jakoba J. Eertink, C. N. Burggraaff, Martijn W. Heymans, et al.
Blood Advances (2021) Vol. 5, Iss. 9, pp. 2375-2384
Open Access | Times Cited: 54
Circulating Tumor DNA in Lymphoma: Principles and Future Directions
Mark Roschewski, Davide Rossi, David M. Kurtz, et al.
Blood Cancer Discovery (2021) Vol. 3, Iss. 1, pp. 5-15
Open Access | Times Cited: 54
Mark Roschewski, Davide Rossi, David M. Kurtz, et al.
Blood Cancer Discovery (2021) Vol. 3, Iss. 1, pp. 5-15
Open Access | Times Cited: 54
Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma
Andrea Kühnl, Claire Roddie, Amy A. Kirkwood, et al.
Blood Advances (2021) Vol. 6, Iss. 1, pp. 321-326
Open Access | Times Cited: 54
Andrea Kühnl, Claire Roddie, Amy A. Kirkwood, et al.
Blood Advances (2021) Vol. 6, Iss. 1, pp. 321-326
Open Access | Times Cited: 54
Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options
Prokop Vodička, Pavel Klener, Marek Trněný
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 1481-1501
Open Access | Times Cited: 33
Prokop Vodička, Pavel Klener, Marek Trněný
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 1481-1501
Open Access | Times Cited: 33
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy
Ajlan Al Zaki, Lei Feng, Grace Watson, et al.
Blood Advances (2022) Vol. 6, Iss. 9, pp. 2867-2871
Open Access | Times Cited: 32
Ajlan Al Zaki, Lei Feng, Grace Watson, et al.
Blood Advances (2022) Vol. 6, Iss. 9, pp. 2867-2871
Open Access | Times Cited: 32
Liquid biopsy for molecular characterization of diffuse large B‐cell lymphoma and early assessment of minimal residual disease
Miguel Alcoceba, Peter Stewart, María García‐Álvarez, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 1, pp. 109-121
Open Access | Times Cited: 6
Miguel Alcoceba, Peter Stewart, María García‐Álvarez, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 1, pp. 109-121
Open Access | Times Cited: 6
Quantitative PET-based biomarkers in lymphoma: getting ready for primetime
Juan Pablo Alderuccio, Russ Kuker, Fei Yang, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 640-657
Closed Access | Times Cited: 15
Juan Pablo Alderuccio, Russ Kuker, Fei Yang, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 640-657
Closed Access | Times Cited: 15
Quantitative evaluation of lesion response heterogeneity for superior prognostication of clinical outcome
Ojaswita Lokre, Timothy Perk, Amy J. Weisman, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 12, pp. 3505-3517
Open Access | Times Cited: 5
Ojaswita Lokre, Timothy Perk, Amy J. Weisman, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 12, pp. 3505-3517
Open Access | Times Cited: 5
ESR Essentials: imaging of lymphoma—practice recommendations by the European Society of Oncologic Imaging
Doris Leithner, Emanuele Neri, Melvin D’Anastasi, et al.
European Radiology (2025)
Open Access
Doris Leithner, Emanuele Neri, Melvin D’Anastasi, et al.
European Radiology (2025)
Open Access
Prognostic value of interim [18F]FDG PET/CT after immunotherapy-based combinations in extranodal NK/T-cell lymphoma, nasal type
Lei Liu, Shihui Hao, Wanqi Chen, et al.
European Radiology (2025)
Closed Access
Lei Liu, Shihui Hao, Wanqi Chen, et al.
European Radiology (2025)
Closed Access
Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma
Mark Roschewski, Dan L. Longo, J. O. Armitage
JAMA Oncology (2025)
Closed Access
Mark Roschewski, Dan L. Longo, J. O. Armitage
JAMA Oncology (2025)
Closed Access
Multi-Modal Data Fused 3d Neural Network Shows Good Predictive Ability in Recurrence of Complete Response Diffuse Large B-Cell Lymphoma within 5 Years
Ying Zhang, Siwen Wang, Xiaoyue Tan, et al.
(2025)
Closed Access
Ying Zhang, Siwen Wang, Xiaoyue Tan, et al.
(2025)
Closed Access
Prognostic Value of Very Early Interim FDG PET/CT After Single Cycle of Chemotherapy for 10-Year Survival in Diffuse Large B-Cell Lymphoma
Eun Ji Han, Hye Lim Park, Seung‐Ah Yahng, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 926-926
Open Access
Eun Ji Han, Hye Lim Park, Seung‐Ah Yahng, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 926-926
Open Access
Evaluating ΔMTV%, ΔDmax%, and %ΔSUVmax of 18F-FDG PET/CT for mid-treatment efficacy and prognosis in diffuse large B-cell lymphoma
Yali Cui, Yao Li, Wenhao Hu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Yali Cui, Yao Li, Wenhao Hu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Prognosis Prediction of Diffuse Large B-Cell Lymphoma in $^{18}$F-FDG PET Images Based on Multi-Deep-Learning Models
Chunjun Qian, Chong Jiang, Kai Xie, et al.
IEEE Journal of Biomedical and Health Informatics (2024) Vol. 28, Iss. 7, pp. 4010-4023
Closed Access | Times Cited: 3
Chunjun Qian, Chong Jiang, Kai Xie, et al.
IEEE Journal of Biomedical and Health Informatics (2024) Vol. 28, Iss. 7, pp. 4010-4023
Closed Access | Times Cited: 3
Turning the tide in aggressive lymphoma: liquid biopsy for risk-adapted treatment strategies
Steven Wang, Florent Moulière, D. Michiel Pegtel, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 7, pp. 660-672
Closed Access | Times Cited: 3
Steven Wang, Florent Moulière, D. Michiel Pegtel, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 7, pp. 660-672
Closed Access | Times Cited: 3
Functional imaging using radiomic features in assessment of lymphoma
Marius E. Mayerhoefer, Lale Umutlu, Heiko Schöder
Methods (2020) Vol. 188, pp. 105-111
Open Access | Times Cited: 24
Marius E. Mayerhoefer, Lale Umutlu, Heiko Schöder
Methods (2020) Vol. 188, pp. 105-111
Open Access | Times Cited: 24
Prognostic Value of18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen
Laure Michaud, Kurt S. Bantilan, Audrey Mauguen, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 4, pp. 536-541
Open Access | Times Cited: 14
Laure Michaud, Kurt S. Bantilan, Audrey Mauguen, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 4, pp. 536-541
Open Access | Times Cited: 14
Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement
Hongzhi Geng, Sixun Jia, Ying Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Hongzhi Geng, Sixun Jia, Ying Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
